Transcription factor E2F4 facilitates SUMOylation to promote HCC progression through interaction with LIN9.
Ontology highlight
ABSTRACT: SUMOylation plays a crucial role in numerous cellular biological and pathophysiological processes associated with human disease; however, the mechanisms regulating the genes involved in SUMOylation remain unclear. In the present study, E2F transcription factor 4 (E2F4) was identified as an E2F member related to hepatocellular carcinoma (HCC) progression by public database analysis. It was found that E2F4 promoted the proliferation and invasiveness of HCC cells via SUMOylation using Soft agar and Transwell migration assays. Mechanistically, it was demonstrated that E2F4 upregulated the transcript and protein expression levels of baculoviral IAP repeat containing 5, cell division cycle associated 8 and DNA topoisomerase II α using western blotting. Furthermore, the interaction between E2F4 w
SUBMITTER: Ma Z
PROVIDER: S-EPMC11387118 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA